» Articles » PMID: 21462017

Deoxynivalenol Exposure Assessment in a Cohort of Pregnant Women from Bradford, UK

Overview
Publisher Informa Healthcare
Date 2011 Apr 5
PMID 21462017
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Deoxynivalenol (DON) is a ubiquitous contaminant of cereal crops in temperate regions of the world. It causes growth faltering and immune suppression in animals. Limited information is available on DON exposure in UK subpopulations. The objective of this study was to provide DON exposure assessment in a subset of pregnant women scheduled for an elective caesarean in a large multi-ethnic mother/infant birth cohort from Bradford, UK. Women aged 16-44 years (n = 85) provided a urine sample for DON analysis in the last trimester of pregnancy, and concurrently completed a food-frequency questionnaire (FFQ). The urinary DON biomarker was detected in all measured samples (geometric mean (GM) = 10.3 ng DON mg(-1) creatinine, range = 0.5-116.7 ng mg(-1)). Levels were higher in women classified as South Asian in origin (GM: 15.2 ng mg(-1); 95% CI = 10.7-21.5 ng mg(-1)) compared with non-South Asians (GM = 8.6 ng mg(-1); 95% CI = 6.6-11.8 ng mg(-1)), p = 0.02). Estimated DON intake from FFQ data and typical levels of DON contamination of food suggest that this was mainly due to higher levels of exposure from bread, particularly daily intake of DON from chapattis in South Asians (estimated mean = 2.4 µg day(-1); 95% CI = 1.2, 3.7 µg day(-1)) compared with non-South Asians (estimated mean = 0.2 µg day(-1); 95% CI = 0-0.4 µg day(-1)), p < 0.001. This is the first biomarker demonstration of DON exposure in pregnant women, and several urinary DON levels were the highest ever recorded in any study. A larger survey within this birth cohort is warranted to investigate any potential risk to mothers and their babies, from DON exposure during pregnancy.

Citing Articles

Assessment of Mycotoxin Exposure and Associated Risk in Pregnant Dutch Women: The Human Biomonitoring Approach.

McKeon H, Schepens M, van den Brand A, de Jong M, van Gelder M, Hesselink M Toxins (Basel). 2024; 16(6).

PMID: 38922172 PMC: 11209130. DOI: 10.3390/toxins16060278.


Prenatal exposure to environmental contaminants and cord serum metabolite profiles in future immune-mediated diseases.

Karthikeyan B, Hyotylainen T, Ghaffarzadegan T, Triplett E, Oresic M, Ludvigsson J J Expo Sci Environ Epidemiol. 2024; 34(4):647-658.

PMID: 38678133 PMC: 11303251. DOI: 10.1038/s41370-024-00680-z.


Adverse associations between maternal deoxynivalenol exposure and birth outcomes: a prospective cohort study in China.

Tan T, Chen T, Zhu W, Gong L, Yan Y, Li Q BMC Med. 2023; 21(1):328.

PMID: 37635232 PMC: 10464359. DOI: 10.1186/s12916-023-03011-5.


Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feed.

Knutsen H, Alexander J, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S EFSA J. 2020; 15(9):e04718.

PMID: 32625635 PMC: 7010102. DOI: 10.2903/j.efsa.2017.4718.


Human Mycotoxin Biomonitoring: Conclusive Remarks on Direct or Indirect Assessment of Urinary Deoxynivalenol.

Vidal A, Bouzaghnane N, De Saeger S, De Boevre M Toxins (Basel). 2020; 12(2).

PMID: 32102452 PMC: 7076754. DOI: 10.3390/toxins12020139.